A detailed history of Front Row Advisors LLC transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Front Row Advisors LLC holds 480 shares of IBB stock, worth $65,375. This represents 0.02% of its overall portfolio holdings.

Number of Shares
480
Previous 180 166.67%
Holding current value
$65,375
Previous $24,000 170.83%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$132.3 - $140.89 $39,690 - $42,266
300 Added 166.67%
480 $65,000
Q4 2023

Feb 15, 2024

SELL
$112.41 - $137.03 $33,723 - $41,109
-300 Reduced 62.5%
180 $24,000
Q1 2023

May 22, 2023

BUY
$121.97 - $137.23 $50,983 - $57,362
418 Added 674.19%
480 $62,000
Q1 2023

May 15, 2023

SELL
$121.97 - $137.23 $50,983 - $57,362
-418 Reduced 87.08%
62 $48,000
Q3 2018

Nov 13, 2018

SELL
N/A
-300 Reduced 38.46%
480 $49,000
Q4 2017

Feb 01, 2018

BUY
N/A
780
780 $83,000

Others Institutions Holding IBB

About ISHARES BIOTECHNOLOGY ETF


  • Ticker IBB
  • Sector ETFs
  • Industry ETFs
More about IBB
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.